MMP-1 and -3 haplotype is associated with congenital anomalies of the kidney and urinary tract

Pediatric Nephrology

Volumn 29, Issue 5, 2014, Pages 879-884

  Djuric, Tamara ^a   Zivkovic, Maja ^a   Milosevic, Biljana ^b   Andjelevski, Magdalena ^a   Cvetkovic, Mirjana ^c   Kostic, Mirjana ^c   Stankovic, Aleksandra ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

CAKUT; Gene; Matrix metalloproteinase; Obstructive uropathy; Polymorphisms

Indexed keywords

INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; STROMELYSIN;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HARDY WEINBERG DISTRIBUTION LAW; HUMAN; INFANT; KIDNEY MALFORMATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEGAURETER; OBSTRUCTIVE MEGAURETER; OBSTRUCTIVE UROPATHY; POLYMERASE CHAIN REACTION; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; URETEROPELVIC JUNCTION OBSTRUCTION; URINARY TRACT MALFORMATION; VESICOURETERAL REFLUX; GENETIC POLYMORPHISM; GENETICS; KIDNEY; KIDNEY DISEASES; PRESCHOOL CHILD; RISK; SERBIA; URETERAL OBSTRUCTION; URINARY TRACT; UROLOGIC DISEASES;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INFANT; KIDNEY; KIDNEY DISEASES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; POLYMORPHISM, GENETIC; RISK; SERBIA; URETERAL OBSTRUCTION; URINARY TRACT; UROLOGIC DISEASES;

EID: 84898890346     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2699-x     Document Type: Article

References (31)

1. Loane M, Dolk H, Kelly A, Teljeur C, Greenlees R, Densem J, EUROCAT Working Group (2011) Paper 4: EUROCAT statistical monitoring: identification and investigation of ten year trends of congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 91:S31-S43
2. Lenz O, Elliot SJ, Stetler-Stevenson WG (2000) Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11:574-581
3. Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M, Sato H (1998) Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in Madin-Darby canine kidney epithelial cells. Biochem Biophys Res Commun 251:681-687
4. Pohl M, Sakurai H, Bush KT, Nigam SK (2000) Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis. Am J Physiol Renal Physiol 279:F891-F900
5. Engelmyer E, van Goor H, Edwards DR, Diamond JR (1995) Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. J Am Soc Nephrol 5:1675-1683
6. Sharma AK, Mauer SM, Kim Y, Michael AF (1995) Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J Lab Clin Med 125:754-761
7. Kaya C, Bogaert G, de Ridder D, Schwentner C, Fritsch H, Oswald J, Radmayr C (2010) Extracellular matrix degradation and reduced neural density in children with intrinsic ureteropelvic junction obstruction. Urology 761:185-189
8. Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H (2010) Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int 781:69-78
9. Affara M, Dunmore BJ, Sanders DA, Johnson N, Print CG, Charnock-Jones DS (2011) MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms. BMC Genomics 12:43
10. Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ (2003) Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 92:1254-1256
11. Djurić T, Stanković A, Končar I, Radak D, Davidović L, Alavantić D, Zivkovic M (2011) Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study. Atherosclerosis 219:673-678
12. Pendas AM, Santamaria I, Alvarez MV, Pritchard M, Lopez-Otin C (1996) Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 37:266-268
13. Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Control Clin Trials 11:116-128
14. Menashe I, Rosenberg PS, Chen BE (2008) PGA, power calculator for case-control genetic association analyses. BMC Genet 9:36
15. Djurić T, Stojković L, Zivković M, Končar I, Stanković A, Djordjević A, Alavantić D (2012) Matrix metalloproteinase-1 promoter genotypes and haplotypes are associated with carotid plaque presence. Clin Biochem 45:1353-1356
16. Djuric T, Zivkovic M, Mecanin S, Stankovic A, Alavantic D (2005) Endothelial NOS G894T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. J Clin Lab Anal 19:241-246
17. Carter KW, McCaskie PA, Palmer LJ (2006) JLIN: a JAVA-based linkage disequilibrium plotter. BMC Bioinforma 7:60
18. Tregouet DA, Garelle V (2007) A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23:1038-1039
19. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL (2004) A new algorithm for haplotype-based association analysis: the stochastic-EM algorithm. Ann Hum Genet 68:165-177
20. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R (2002) Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408-2412
21. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P (2002) The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J 23:721-725
22. Ye S, Gale CR, Martyn CN (2003) Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 24:1668-1671
23. Pradhan-Palikhe P, Pussinen PJ, Vikatmaa P, Palikhe A, Kivimäki AS, Lepäntalo M, Salo T, Sorsa T (2012) Single-nucleotide polymorphism -799C/T in matrix metalloproteinase-8 promoter region in arterial disease. Innate Immun 18:511-517
24. Hanna MK, Jeffs RD, Sturgess JM, Barkin M (1976) Ureteral structure and ultrastructure. Part II. Congenital ureteropelvic junction obstruction and primary obstructive megaureter. J Urol 116:725-730
25. Lee BR, Silver RI, Partin AW, Epstein JI, Gearhart JP (1998) A quantitative histologic analysis of collagen subtypes: the primary obstructed and refluxing megaureter of childhood. Urology 51:820-823
26. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG (1987) The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 262:10048-10052
27. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ (1987) Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248:265-268
28. Knäuper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H (1993) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 295:581-586
29. Sakai T, Larsen M, Yamada KM (2003) Fibronectin requirement in branching morphogenesis. Nature 423:876-881
30. Fukuda Y, Masuda Y, Kishi J, Hashimoto Y, Hayakawa T, Nogawa H, Nakanishi Y (1988) The role of interstitial collagens in cleft formation of mouse embryonic submandibular gland during initial branching. Development 103:259-267
31. Rebustini IT, Patel VN, Stewart JS, Layvey A, Georges-Labouesse E, Miner JH, Hoffman MP (2007) Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling. Dev Biol 308:15-29